Table 2 CD105 immunohistochemical localization in primary salivary gland tumors (IMD = intratumoral microvessel density) [14].
| Â | Â | CD105 positivity | |
|---|---|---|---|
Type and metastatic status | N | Frequency | IMD (mean ± SD) |
Adenoid cystic carcinoma | Â | Â | Â |
Primary, non-metastasizing | 41 | 2.4% | 0 |
Primary, metastasizing | 10 | 30.0% | 0.7 (± 1.3) |
Polymorphous low-grade adenocarcinoma | Â | Â | Â |
Primary, non-metastasizing | 17 | 47.1% | 1.6 (± 2.0) |
Primary, metastasizing | 2 | 0 | 0 |
Mucoepidermoid carcinoma | Â | Â | Â |
Primary, non-metastasizing | 36 | 83.3% | 4.8 (± 6.0) |
Primary, metastasizing | 4 | 100% | 6.2 (± 2.1) |